The Journal of Urology 1982-04-01

Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).

B Hartley-Asp, P O Gunnarsson

Index: J. Urol. 127(4) , 818-22, (1982)

Full Text: HTML

Abstract

Estramustine at concentrations ranging from 3-40 x 10(-6) M inhibited the cell growth and clonogenic survival of a human prostatic carcinoma cell line (DU 145). This cell line was found to be unresponsive to estradiol and testosterone at concentrations ranging from 10(-9) M to 5 x 10(-5) M. Metabolism studies with estramustine showed that only a few per cent of the ester linkage was cleaved during the exposure period. This small amount of metabolism could possibly lead to the release of nor-nitrogen mustard, which was however found not to be as inhibitory as estramustine in this cell line. The results indicate that estramustine per se causes the cell death of hormone unresponsive human prostatic carcinoma cells in cell culture.

Related Compounds

  • Bis(2-Chloroethyl...

Related Articles:

Occupational exposure to nor-nitrogen mustard: chemical and biological monitoring.

1995-01-01

[Toxicol. Ind. Health 11(1) , 89-97, (1995)]

Basic principles in preclinical cancer chemotherapy.

1990-01-01

[J. Cancer Res. Clin. Oncol. 116(5) , 411-24, (1990)]

Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin.

2002-03-01

[Arch. Toxicol. 76(2) , 83-8, (2002)]

The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.

1994-03-01

[Biol. Mass Spectrom. 23(3) , 149-58, (1994)]

Oxazolidonylethyl adducts to hemoglobin and DNA following nornitrogen mustard exposure.

1996-01-05

[Chem. Biol. Interact. 99(1-3) , 263-75, (1996)]

More Articles...